Neuroprotection with Statin Therapy for Acute Recovery Trial (Neu START):A Phase 2 safety and pilot efficacy study of lovastatin for the treatment of acute ischemic stroke [SPOTRIAS] "NeuSTART II"

Recruiting

Phase N/A Results N/A

Summary of Purpose

To determine whether lovastatin 640 mg daily for 3 days beginning within 24 hours after acute stroke can be administered safely (<10 percentage points higher risk of myotoxicity and/or hepatotoxicity). To assess efficacy of lovastatin administered at high doses.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 May 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • The National Institute of Neurological Disorders and Stroke (NINDS) 1 P50 NS049060

Trial Design

Interventional, randomized, blinded and controlled safety study.

Contacts

  • Tania E. Corporan, MD Columbia University Medical Center New York, NY 10032 Ph: 212-305-7755

    tcorporan@neuro.columbia.edu